Cardiometabolic Risk Factors and Atrial Fibrillation Article

Full Text via DOI: 10.3909/ricm0693 PMID: 24448257 Web of Science: 000209311500001

Cited authors

  • Menezes, Arthur R.; Lavie, Carl J.; DiNicolantonio, James J.; O'Keefe, James; Morin, Daniel P.; Khatib, Sammy; Messerli, Franz H.; Milani, Richard V.


  • Atrial fibrillation (AF) is the most common arrhythmia worldwide; it is a significant risk factor for stroke and embolization, and has an impact on cardiac function. Despite its impact on morbidity and mortality, our understanding of the etiology and pathophysiology of this disease process is still incomplete. Over the past several decades, there has been evidence to suggest that AF has a significant correlation with metabolic syndrome (MetS). Furthermore, AF appears to be more closely related to specific components of MetS compared with others. This article provides an overview of the various components of MetS and their impact on AF.

Publication date

  • 2013

Published in

International Standard Serial Number (ISSN)

  • 1530-6550

Start page

  • E73

End page

  • E81


  • 14


  • 2-4